Angus C. Russell - Dec 13, 2021 Form 4 Insider Report for Revance Therapeutics, Inc. (RVNC)

Role
Director
Signature
/s/ Gordon Ho, Attorney-in-Fact
Stock symbol
RVNC
Transactions as of
Dec 13, 2021
Transactions value $
$100,741
Form type
4
Date filed
12/15/2021, 07:17 PM
Previous filing
Aug 12, 2021
Next filing
May 13, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RVNC Common Stock Purchase $101K +6.4K +31.2% $15.74 26.9K Dec 13, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Table 1, Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $15.65 to $15.81. Mr. Russell undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.